Hlectron

Hlectron (pronounced "electron") is developing advanced medical systems aimed at increasing the efficacy of cancer treatments and reducing the burden of cancer on society, by leveraging the power of electromagnetic nanotechnology developed at The University of Cambridge in the UK.

Specifically, Hlectron has developed two medical systems, MagTherm and NanoMagTherm demonstrated to increase the survival rates by 20% (locally advanced breast cancer patients) to more than 50% (animal clinical data). MagTherm is complemntary to chemotherapy, while NanoMagTherm is a stand-alone treatment protocol. 

Hlectron has received the Seal of Excellence from the European Commission.